1
|
Liu ZS, Sinha S, Bannister M, Song A, Arriaga-Gomez E, McKeeken AJ, Bonner EA, Hanson BK, Sarchi M, Takashima K, Zong D, Corral VM, Nguyen E, Yoo J, Chiraphapphaiboon W, Leibson C, McMahon MC, Rai S, Swisher EM, Sachs Z, Chatla S, Stirewalt DL, Deeg HJ, Skorski T, Papapetrou EP, Walter MJ, Graubert TA, Doulatov S, Lee SC, Nguyen HD. R-Loop Accumulation in Spliceosome Mutant Leukemias Confers Sensitivity to PARP1 Inhibition by Triggering Transcription-Replication Conflicts. Cancer Res 2024; 84:577-597. [PMID: 37967363 PMCID: PMC10922727 DOI: 10.1158/0008-5472.can-23-3239] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/16/2023] [Revised: 11/09/2023] [Accepted: 11/13/2023] [Indexed: 11/17/2023]
Abstract
RNA splicing factor (SF) gene mutations are commonly observed in patients with myeloid malignancies. Here we showed that SRSF2- and U2AF1-mutant leukemias are preferentially sensitive to PARP inhibitors (PARPi), despite being proficient in homologous recombination repair. Instead, SF-mutant leukemias exhibited R-loop accumulation that elicited an R-loop-associated PARP1 response, rendering cells dependent on PARP1 activity for survival. Consequently, PARPi induced DNA damage and cell death in SF-mutant leukemias in an R-loop-dependent manner. PARPi further increased aberrant R-loop levels, causing higher transcription-replication collisions and triggering ATR activation in SF-mutant leukemias. Ultimately, PARPi-induced DNA damage and cell death in SF-mutant leukemias could be enhanced by ATR inhibition. Finally, the level of PARP1 activity at R-loops correlated with PARPi sensitivity, suggesting that R-loop-associated PARP1 activity could be predictive of PARPi sensitivity in patients harboring SF gene mutations. This study highlights the potential of targeting different R-loop response pathways caused by spliceosome gene mutations as a therapeutic strategy for treating cancer. SIGNIFICANCE Spliceosome-mutant leukemias accumulate R-loops and require PARP1 to resolve transcription-replication conflicts and genomic instability, providing rationale to repurpose FDA-approved PARP inhibitors for patients carrying spliceosome gene mutations.
Collapse
Affiliation(s)
- Zhiyan Silvia Liu
- Molecular Pharmacology and Therapeutics Graduate Program, Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
- These authors contributed equally
| | - Sayantani Sinha
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- These authors contributed equally
| | - Maxwell Bannister
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | - Axia Song
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Erica Arriaga-Gomez
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Alexander J. McKeeken
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
- Bioinformatics and Computational Biology Program, University of Minnesota, Minneapolis, MN, USA
| | - Elizabeth A. Bonner
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- Molecular and Cellular Biology Graduate Program, University of Washington, Seattle, WA, USA
| | - Benjamin K. Hanson
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
- Department of Biochemistry, Molecular Biology, and Biophysics Graduate Program, University of Minnesota, Minneapolis, MN, USA
| | - Martina Sarchi
- Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
- Department of Molecular Medicine, University of Pavia, 27100 Pavia PV, Italy
| | - Kouhei Takashima
- Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Institute for Regenerative Medicine and Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Dawei Zong
- Molecular Pharmacology and Therapeutics Graduate Program, Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | - Victor M. Corral
- Molecular Pharmacology and Therapeutics Graduate Program, Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | - Evan Nguyen
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Jennifer Yoo
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | | | - Cassandra Leibson
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | - Matthew C. McMahon
- Molecular Pharmacology and Therapeutics Graduate Program, Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
| | - Sumit Rai
- Massachusetts General Hospital Cancer Center, Charlestown, MA
| | - Elizabeth M. Swisher
- Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University of Washington School of Medicine, Seattle, WA 98195
| | - Zohar Sachs
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
- Division of Hematology, Oncology, and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, MN, USA
| | - Srinivas Chatla
- Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
| | - Derek L. Stirewalt
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - H. Joachim Deeg
- Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
| | - Tomasz Skorski
- Fels Cancer Institute for Personalized Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
- Department of Cancer and Cellular Biology, Lewis Katz School of Medicine, Temple University, Philadelphia, PA 19140, USA
| | - Eirini P. Papapetrou
- Department of Oncological Sciences, Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Institute for Regenerative Medicine and Black Family Stem Cell Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- Center for Advancement of Blood Cancer Therapies, Icahn School of Medicine at Mount Sinai, New York, NY, USA
| | - Matthew J. Walter
- Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St Louis, MO, USA
| | | | - Sergei Doulatov
- Division of Hematology and Oncology, Department of Medicine, University of Washington, Seattle, WA, USA
- Department of Genome Sciences, University of Washington, Seattle, WA, USA
- Institute of Stem Cell and Regenerative Medicine, University of Washington, Seattle, WA, USA
| | - Stanley C. Lee
- Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- Department of Laboratory Medicine & Pathology, University of Washington, Seattle, WA, USA
| | - Hai Dang Nguyen
- Masonic Cancer Center, University of Minnesota, Minneapolis, MN, USA
- Department of Pharmacology, University of Minnesota, Minneapolis, MN, USA
| |
Collapse
|
3
|
Del Río LE, Bradley CA, Henson RA, Endres GJ, Hanson BK, McKay K, Halvorson M, Porter PM, Le Gare DG, Lamey HA. Impact of Sclerotinia Stem Rot on Yield of Canola. Plant Dis 2007; 91:191-194. [PMID: 30781003 DOI: 10.1094/pdis-91-2-0191] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 05/22/2023]
Abstract
Sclerotinia sclerotiorum is the causal agent of Sclerotinia stem rot (SSR) of canola (Brassica napus). In North Dakota, the leading canola producer in the United States, SSR is an endemic disease. In order to estimate the impact of this disease on canola yield, field experiments were conducted from 2000 to 2004 at several locations in North Dakota and Minnesota. Experimental plots were either inoculated with laboratory-produced ascospores or infected by naturally occurring inoculum in commercial fields. Applying fungicides at different concentrations and timings during the flowering period created epiphytotics of diverse intensities. Disease incidence was measured once prior to harvesting the crop on 50 to 100 plants per plot. Results of the study indicated that 0.5% of the potential yield (equivalent to 12.75 kg/ha) was lost for every unit percentage of SSR incidence (range of 0.18 to 0.96%). Considering the current cost of fungicide applications and the market value of this commodity, a 17% SSR incidence could cause losses similar to the cost of a fungicide application. Additional efforts are required to improve current levels of tolerance of canola plants to this pathogen.
Collapse
Affiliation(s)
- L E Del Río
- Department of Plant Pathology, North Dakota State University, Fargo 58105
| | - C A Bradley
- Department of Plant Pathology, North Dakota State University, Fargo 58105
| | - R A Henson
- Carrington Research Extension Center, North Dakota State University, Carrington 58421
| | - G J Endres
- Carrington Research Extension Center, North Dakota State University, Carrington 58421
| | - B K Hanson
- Langdon Research Extension Center, North Dakota State University, Langdon 58249
| | - K McKay
- North Central Research Extension Center, North Dakota State University, Minot 58701
| | - M Halvorson
- North Central Research Extension Center, North Dakota State University, Minot 58701
| | - P M Porter
- Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul 55108
| | - D G Le Gare
- Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul 55108
| | - H A Lamey
- Department of Plant Pathology, North Dakota State University, Fargo
| |
Collapse
|
4
|
Bradley CA, Lamey HA, Endres GJ, Henson RA, Hanson BK, McKay KR, Halvorson M, LeGare DG, Porter PM. Efficacy of Fungicides for Control of Sclerotinia Stem Rot of Canola. Plant Dis 2006; 90:1129-1134. [PMID: 30781091 DOI: 10.1094/pd-90-1129] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 06/09/2023]
Abstract
Sclerotinia stem rot (SSR), incited by Sclerotinia sclerotiorum, causes yield reductions to canola (Brassica napus) grown in North Dakota and Minnesota. Field trials were conducted in North Dakota and Minnesota from 2000 to 2004 to evaluate the effect of foliar fungicides on SSR and canola yield. Levels of SSR varied among years and location. In general, fungicides that consistently reduced SSR incidence compared with an untreated control were azoxystrobin, benomyl, boscalid, iprodione, prothioconazole, tebuconazole, thiophanate-methyl, trifloxystrobin, and vinclozolin. Significant reductions in SSR incidence with fungicides did not always translate into differences in canola yield, however. Inconsistent results were observed with different timings of applications based on percent bloom. This indicates that application timing should be based on factors in addition to percent bloom.
Collapse
Affiliation(s)
- C A Bradley
- Department of Plant Pathology, North Dakota State University, Fargo 58105
| | - H A Lamey
- Department of Plant Pathology, North Dakota State University, Fargo 58105
| | - G J Endres
- Carrington Research Extension Center, North Dakota State University, Carrington, 58421
| | - R A Henson
- Carrington Research Extension Center, North Dakota State University, Carrington, 58421
| | - B K Hanson
- Langdon Research Extension Center, North Dakota State University, Langdon 58249
| | - K R McKay
- North Central Research Extension Center, North Dakota State University, Minot 58701
| | - M Halvorson
- North Central Research Extension Center, North Dakota State University, Minot 58701
| | - D G LeGare
- Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul 55108
| | - P M Porter
- Department of Agronomy and Plant Genetics, University of Minnesota, St. Paul 55108
| |
Collapse
|